AIM ImmunoTech Inc（AIM）美股招股说明书 S-1（2026-06-18首版）（英文版）（44页）.pdf

1、S-1 1 forms-1.htm S-1 As filed with the Securities and Exchange Commission on June 18,2026 Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM S-1REGISTRATION STATEMENTUnderThe Securities Act of 1933 AIM ImmunoTech Inc.(Exact name of Registrant as specified i

2、n its charter)Delaware 2836 52-0845822(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)2117 SW Highway 484Ocala,FL 34473(352)448-7797(Address,including zip code,and telephone number,includingarea

3、code,of Registrants principal executive offices)Thomas K.EquelsChief Executive OfficerAIM ImmunoTech Inc.2117 SW Highway 484Ocala,FL 34473(352)448-7797(Name,address,including zip code,and telephone number,includingarea code,of agent for service)Copies of all communications,including communications s

4、ent to the agent for service,to:Faith L.CharlesThompson Hine LLP300 Madison Avenue,27th FloorNew York,New York 10017-6232Phone:(212)344-5680Fax:(212)344-6101 Approximate date of commencement of proposed sale to the public:As soon as practicable after this registration statementbecomes effective.If a

5、ny of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 underthe Securities Act of 1933 check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,p

6、lease checkthe following box and list the Securities Act registration statement number of the earlier effective registration statement for thesame offering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securities Act,check the following box and listthe Securities